CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
17.28
1.71%
Market Trading Hours* (UTC) Opens on Wednesday at 14:30

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading сonditions
Spread 0.14
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026151 %
Charges from full value of position ($-1.05)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.026151%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003929 %
Charges from full value of position ($0.16)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
0.003929%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 20%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Sotera Health Co ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 16.99
Open* 15.13
1-Year Change* -11.93%
Day's Range* 15.13 - 17.38
52 wk Range 12.34-19.40
Average Volume (10 days) 831.95K
Average Volume (3 months) 16.20M
Market Cap 4.16B
P/E Ratio -100.00K
Shares Outstanding 282.62M
Revenue 990.64M
EPS -1.09
Dividend (Yield %) N/A
Beta -100.00K
Next Earnings Date Feb 27, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 26, 2024 16.99 1.02 6.39% 15.97 17.04 15.97
Feb 23, 2024 16.76 0.64 3.97% 16.12 16.84 16.12
Feb 22, 2024 16.54 0.46 2.86% 16.08 16.54 16.08
Feb 21, 2024 16.29 0.73 4.69% 15.56 16.48 15.56
Feb 20, 2024 16.14 -0.02 -0.12% 16.16 16.40 16.09
Feb 16, 2024 16.56 0.11 0.67% 16.45 16.69 16.36
Feb 15, 2024 16.74 0.13 0.78% 16.61 17.09 16.60
Feb 14, 2024 16.60 1.13 7.30% 15.47 16.66 15.47
Feb 13, 2024 15.85 0.22 1.41% 15.63 16.19 15.59
Feb 12, 2024 16.07 0.08 0.50% 15.99 16.42 15.95
Feb 9, 2024 16.20 0.73 4.72% 15.47 16.25 15.44
Feb 8, 2024 15.94 1.02 6.84% 14.92 15.96 14.76
Feb 7, 2024 15.17 -0.47 -3.01% 15.64 15.69 15.12
Feb 6, 2024 15.57 0.53 3.52% 15.04 15.61 14.85
Feb 5, 2024 15.05 0.32 2.17% 14.73 15.17 14.52
Feb 2, 2024 14.99 0.29 1.97% 14.70 15.12 14.69
Feb 1, 2024 15.27 0.69 4.73% 14.58 15.40 14.45
Jan 31, 2024 14.66 0.17 1.17% 14.49 14.89 14.25
Jan 30, 2024 14.58 -0.12 -0.82% 14.70 14.89 14.53
Jan 29, 2024 14.97 0.40 2.75% 14.57 14.99 14.57

Sotera Health Co Events

Time (UTC) Country Event
Wednesday, May 1, 2024

Time (UTC)

12:30

Country

US

Event

Q1 2024 Sotera Health Co Earnings Release
Q1 2024 Sotera Health Co Earnings Release

Forecast

-

Previous

-
Friday, May 24, 2024

Time (UTC)

13:00

Country

US

Event

Sotera Health Co Annual Shareholders Meeting
Sotera Health Co Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 1003.69 931.478 818.158 778.327 746.149
Revenue 1003.69 931.478 818.158 778.327 746.149
Cost of Revenue, Total 446.683 412.806 374.586 382.896 388.897
Gross Profit 557.004 518.672 443.572 395.431 357.252
Total Operating Expense 1172.95 695.426 656.402 624.898 665.302
Selling/General/Admin. Expenses, Total 245.714 198.158 178.525 147.48 133.363
Depreciation / Amortization 62.94 63.781 59.029 58.562 57.975
Unusual Expense (Income) 417.613 20.681 44.262 35.96 85.067
Operating Income -169.263 236.052 161.756 153.429 80.847
Interest Income (Expense), Net Non-Operating -80.289 -75.537 -210.029 -160.391 -155.401
Gain (Loss) on Sale of Assets 0 95.91
Other, Net 6.441 15.201 9.413 6.046 2.866
Net Income Before Taxes -243.111 175.716 -38.86 -0.916 24.222
Net Income After Taxes -233.57 117.121 -37.491 -20.425 -5.876
Minority Interest 0 -0.239 -1.126 -0.425 0.006
Net Income Before Extra. Items -233.57 116.882 -38.617 -20.85 -5.87
Net Income -233.57 116.882 -38.617 -20.85 -5.87
Income Available to Common Excl. Extra. Items -233.57 115.358 -38.617 -20.85 -5.87
Income Available to Common Incl. Extra. Items -233.57 115.358 -38.617 -20.85 -5.87
Diluted Net Income -233.57 115.358 -38.617 -20.85 -5.87
Diluted Weighted Average Shares 280.096 279.382 285.99 277.432 277.432
Diluted EPS Excluding Extraordinary Items -0.83389 0.4129 -0.13503 -0.07515 -0.02116
Dividends per Share - Common Stock Primary Issue 0 0
Diluted Normalized EPS 0.32355 0.56644 0.08184 0.0091 -0.04656
Total Adjustments to Net Income 0 -1.524
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 255.282 220.59 251.59 248.704 503.393
Revenue 255.282 220.59 251.59 248.704 503.393
Cost of Revenue, Total 115.694 109.087 109.87 112.691 224.122
Gross Profit 139.588 111.503 141.72 136.013 279.271
Total Operating Expense 192.078 187.224 599.422 185.509 388.019
Selling/General/Admin. Expenses, Total 60.287 61.91 65.949 57.091 122.674
Depreciation / Amortization 16.097 16.227 15.603 15.727 31.61
Unusual Expense (Income) 0 0 408 0 9.613
Operating Income 63.204 33.366 -347.832 63.195 115.374
Interest Income (Expense), Net Non-Operating -31.193 -29.217 -32.916 -22.892 -24.481
Other, Net 2.474 1.253 2.246 1.713 2.482
Net Income Before Taxes 34.485 5.402 -378.502 42.016 93.375
Net Income After Taxes 23.513 2.842 -319.719 25.09 61.059
Minority Interest 0 0 0
Net Income Before Extra. Items 23.513 2.842 -319.719 25.09 61.059
Net Income 23.513 2.842 -319.719 25.09 61.059
Total Adjustments to Net Income -0.137 -0.022 0.862 -0.223 -0.639
Income Available to Common Excl. Extra. Items 23.376 2.82 -318.857 24.867 60.42
Income Available to Common Incl. Extra. Items 23.376 2.82 -318.857 24.867 60.42
Diluted Net Income 23.376 2.82 -318.857 24.867 60.42
Diluted Weighted Average Shares 283.147 283.094 280.42 280.172 280.133
Diluted EPS Excluding Extraordinary Items 0.08256 0.00996 -1.13707 0.08876 0.21568
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS 0.13237 0.0444 -0.1348 0.12843 0.32715
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 645.01 345.961 315.015 252.354 312.862
Cash and Short Term Investments 395.214 106.917 102.447 62.863 96.272
Cash & Equivalents 395.214 106.917 102.447 62.863 96.272
Total Receivables, Net 155.717 130.903 115.598 100.323 120.341
Accounts Receivable - Trade, Net 138.259 123.748 91.735 88.644 100.01
Total Inventory 37.145 54.288 34.093 37.396 37.599
Prepaid Expenses 44.032 46.535 54.85 43.434 49.19
Other Current Assets, Total 12.902 7.318 8.027 8.338 9.46
Total Assets 3117.71 2789.5 2761.28 2580.67 2708.58
Property/Plant/Equipment, Total - Net 801.008 690.743 655.777 581.954 586.436
Property/Plant/Equipment, Total - Gross 1239.9 1081.14 997.327 876.516 821.053
Accumulated Depreciation, Total -438.896 -390.394 -341.55 -294.562 -234.617
Goodwill, Net 1101.77 1120.32 1115.94 1035.86 1023.31
Intangibles, Net 483.962 590.686 635.188 688.121 757.844
Other Long Term Assets, Total 85.957 32.387 25.906 22.38 28.128
Total Current Liabilities 791.567 161.161 140.598 123.99 143.374
Accounts Payable 74.139 72.868 52.4 42.004 46.355
Accrued Expenses 488.858 67.025 66.154 54.857 71.215
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 198.841 1.16 1.173 17.619 16.695
Other Current Liabilities, Total 29.729 20.108 20.871 9.51 9.109
Total Liabilities 2767.47 2203.41 2308.98 3223.25 2664.23
Total Long Term Debt 1804.07 1784.41 1859.73 2830.76 2221.1
Long Term Debt 1747.11 1743.53 1824.79 2800.87 2189.56
Capital Lease Obligations 56.955 40.877 34.939 29.883 31.535
Deferred Income Tax 68.024 134.501 121.816 137.235 171.482
Minority Interest 0 0 15.897 15.067 14.757
Other Liabilities, Total 103.806 123.333 170.938 116.2 113.514
Total Equity 350.238 586.096 452.302 -642.574 44.359
Common Stock 2.86 2.86 2.86 2.324 2.324
Additional Paid-In Capital 1189.62 1172.59 1166.41 0 162.409
Retained Earnings (Accumulated Deficit) -705.816 -472.246 -589.128 -550.511 -10.417
Other Equity, Total -106.653 -83.566 -93.842 -94.387 -109.957
Total Liabilities & Shareholders’ Equity 3117.71 2789.5 2761.28 2580.67 2708.58
Total Common Shares Outstanding 282.421 282.985 283.248 277.432 277.432
Long Term Investments 0 9.405 13.457
Treasury Stock - Common -29.775 -33.545 -34
Preferred Stock - Non Redeemable, Net 0
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 519.646 546.692 923.799 645.01 420.734
Cash and Short Term Investments 244.959 262.7 647.948 395.214 163.975
Cash & Equivalents 244.959 262.7 647.948 395.214 163.975
Total Receivables, Net 176.605 167.59 154.04 155.717 164.454
Accounts Receivable - Trade, Net 143.927 136.107 127.899 138.259 134
Total Inventory 37.924 42.102 46.736 37.145 37.153
Prepaid Expenses 39.331 50.334 48.463 44.032 38.754
Other Current Assets, Total 20.827 23.966 26.612 12.902 16.398
Total Assets 3036.57 3074.87 3414.17 3117.71 2810.63
Property/Plant/Equipment, Total - Net 909.057 884.317 841.105 801.008 731.6
Goodwill, Net 1100.81 1110.5 1103.42 1101.77 1092.47
Intangibles, Net 422.363 449.283 464.581 483.962 496.619
Long Term Investments 0 0
Other Long Term Assets, Total 84.697 84.08 81.268 85.957 69.21
Total Current Liabilities 200.594 200.33 600.149 791.567 140.031
Accounts Payable 57.125 55.58 61.939 74.139 60.73
Accrued Expenses 102.548 103.909 495.666 488.858 56.064
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 13.633 13.83 12.619 198.841 1.591
Other Current Liabilities, Total 27.288 27.011 29.925 29.729 21.646
Total Liabilities 2659.1 2656.5 3053.05 2767.47 2203.9
Total Long Term Debt 2286.01 2283.27 2284.07 1804.07 1801.49
Long Term Debt 2222.79 2221.99 2222.33 1747.11 1746.56
Capital Lease Obligations 63.219 61.283 61.735 56.955 54.935
Deferred Income Tax 68.826 68.194 63.226 68.024 151.72
Minority Interest 0 0
Other Liabilities, Total 103.675 104.709 105.605 103.806 110.662
Total Equity 377.471 418.367 361.125 350.238 606.729
Common Stock 2.86 2.86 2.86 2.86 2.86
Additional Paid-In Capital 1210.35 1202.97 1195.36 1189.62 1186.62
Retained Earnings (Accumulated Deficit) -693.121 -679.461 -702.974 -705.816 -386.097
Treasury Stock - Common -28.474 -28.7 -29.42 -29.775 -32.653
Other Equity, Total -114.14 -79.304 -104.698 -106.653 -164.001
Total Liabilities & Shareholders’ Equity 3036.57 3074.87 3414.17 3117.71 2810.63
Total Common Shares Outstanding 282.623 282.544 282.517 282.421 282.113
Preferred Stock - Non Redeemable, Net 0 0
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -233.57 117.121 -37.491 -20.425 -5.876
Cash From Operating Activities 277.961 281.545 120.585 149.041 119.563
Cash From Operating Activities 64 64.16 63.309 66.671 66.91
Amortization 81.554 86.742 80.254 80.048 79.906
Deferred Taxes -73.96 -3.716 -23.36 -18.993 -45.317
Non-Cash Items 30.703 29.829 49.666 50.091 19.905
Cash Taxes Paid 75.496 52.007 23.988 44.614 68.61
Cash Interest Paid 75.849 58.772 211.276 151.005 138.85
Changes in Working Capital 409.234 -12.591 -11.793 -8.351 4.035
Cash From Investing Activities -181.896 -159.833 -158.694 -57.257 96.638
Capital Expenditures -182.378 -102.162 -53.507 -57.257 -72.613
Other Investing Cash Flow Items, Total 0.482 -57.671 -105.187 0 169.251
Cash From Financing Activities 197.761 -117.286 73.432 -126.03 -191.857
Financing Cash Flow Items -2.239 -17.286 -21.204 -709.546 -177.223
Issuance (Retirement) of Debt, Net 200 -100 -1027.32 583.516 -14.634
Foreign Exchange Effects -4.456 0.044 4.106 0.485 -3.676
Net Change in Cash 289.37 4.47 39.429 -33.761 20.668
Issuance (Retirement) of Stock, Net 0 0 1121.96
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 2.842 -233.57 86.149 61.059 30.641
Cash From Operating Activities 33.871 277.961 176.035 108.256 49.967
Cash From Operating Activities 18.931 64 47.496 31.611 15.867
Amortization 20.607 81.554 61.596 41.378 20.182
Deferred Taxes -1.77 -73.96 17.153 10.416 5.633
Non-Cash Items 9.471 30.703 14.43 13.108 -0.451
Cash Taxes Paid 14.014 75.496 56.474 37.34 13.505
Cash Interest Paid 35.456 75.849 65.045 42.057 15.809
Changes in Working Capital -16.21 409.234 -50.789 -49.316 -21.905
Cash From Investing Activities -44.968 -181.896 -110.158 -71.192 -35.483
Capital Expenditures -45 -182.378 -110.642 -71.642 -35.546
Other Investing Cash Flow Items, Total 0.032 0.482 0.484 0.45 0.063
Cash From Financing Activities 273.916 197.761 -1.483 -1.083 -0.449
Financing Cash Flow Items -26.084 -2.239 -1.483 -1.083 -0.449
Issuance (Retirement) of Debt, Net 300 200 0
Foreign Exchange Effects 1.067 -4.456 -6.357 -2.287 0.487
Net Change in Cash 263.886 289.37 58.037 33.694 14.522
Issuance (Retirement) of Stock, Net 0
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Warburg Pincus LLC Private Equity 37.3006 105417315 0 2023-06-30 LOW
GTCR Golder Rauner, LLC Private Equity 24.8671 70278209 0 2023-06-30 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.3616 9500464 -1025 2023-06-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 2.8255 7985288 -132125 2023-06-30 LOW
Petras (Michael B. Jr.) Individual Investor 2.2976 6493417 107783 2023-03-31 LOW
Janus Henderson Investors Investment Advisor/Hedge Fund 2.1373 6040308 3420646 2023-06-30 LOW
ArrowMark Colorado Holdings, LLC Investment Advisor/Hedge Fund 1.7995 5085551 297775 2023-06-30 MED
Citadel Advisors LLC Hedge Fund 1.3685 3867529 -1432948 2023-06-30 LOW
MIG Capital, LLC Investment Advisor 1.2938 3656473 -15935 2023-06-30
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.9629 2721185 -46219 2023-06-30 LOW
Schroder Investment Management North America Inc. Investment Advisor 0.9566 2703543 477346 2023-06-30 LOW
Hawk Ridge Capital Management LP Hedge Fund 0.7891 2230014 386500 2023-06-30 HIGH
William Blair Investment Management, LLC Investment Advisor/Hedge Fund 0.6941 1961646 185883 2023-06-30 LOW
Millennium Management LLC Hedge Fund 0.6518 1842077 -1974373 2023-06-30 HIGH
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.6079 1717983 79033 2023-06-30 LOW
First Trust Advisors L.P. Investment Advisor 0.5163 1459006 655762 2023-06-30 MED
Boston Partners Investment Advisor/Hedge Fund 0.4596 1298879 -1713956 2023-06-30 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.4353 1230323 446046 2023-06-30 LOW
P2 Capital Partners, LLC Hedge Fund 0.4069 1150000 1150000 2023-06-30 LOW
MFS Investment Management Investment Advisor/Hedge Fund 0.3712 1049163 42797 2023-06-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Sotera Health Co Company profile

About Sotera Health Co

Sotera Health Company. is a provider of sterilization, lab testing and advisory services to the medical device and pharmaceutical industries. The Company operates through three segments: Sterigenics, Nordion and Nelson Labs. The Sterilization Services includes products, such as procedure kits and trays, implants, syringes, catheters, wound care products, medical protective barriers, including personal protective equipment (PPE), laboratory products and pharmaceuticals. Its lab testing and advisory services offer microbiological and analytical chemistry laboratory tests across the medical device and pharmaceutical industries. Its medical device testing services include microbiology, biocompatibility and toxicology assessments, material characterization, sterilization validation, sterility assurance. Its pharmaceutical lab testing services include microbiology, biocompatibility and toxicology assessments, extractables and leachables evaluations of pharmaceutical containers.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Sotera Health Co revenues increased 14% to $931.5M. Net income applicable to common stockholders totaled $115.4M vs. loss of $38.6M. Revenues reflect Sterigenics segment increase of 15% to $571.8M, Nordion segment increase of 22% to $140.5M, Canada segment increase of 31% to $177.9M, United States segment increase of 8% to $527.9M. Net Income reflects Interest expense.

Industry: Healthcare Facilities & Services (NEC)

9100 South Hills Blvd, Suite 300
Suite 300
BROADVIEW HEIGHTS
OHIO 44147
US

Income Statement

  • Annual
  • Quarterly

News

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?

UK banks will be in the spotlight in the week ahead as the European earnings season continues

16:38, 16 February 2024

Is Big Tech behind the apparent bull market rally?

While the Magnificent Seven have dominated market momentum in recent months, it’s not true that they are the sole drivers of the recent rally in equity markets.

16:05, 8 February 2024

US Earnings Week Ahead: Walt Disney, Uber, and Pepsi Co.

The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.

16:24, 2 February 2024

Bank of England preview: will updated projections show more cuts are expected in 2024?

Markets have no doubt that the BoE will keep its rate unchanged

15:43, 31 January 2024

Meta Platforms Q4 earnings forecast to surge on solid ad revenues

Meta Platforms (META) reports its Q4 results after Wall Street’s closing bell on February 1, 2024. We preview what to expect from the results and analyse the stock’s technicals.

15:33, 31 January 2024

Federal Reserve meeting preview: strong data is making it hard to justify cutting rates

Markets expect the Fed to keep rates unchanged as strong economic data continues

11:30, 30 January 2024

People also watch

XRP/USD

0.60 Price
+6.990% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

US100

17,973.20 Price
+0.380% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0039%
Overnight fee time 22:00 (UTC)
Spread 1.8

Oil - Crude

78.25 Price
+0.970% 1D Chg, %
Long position overnight fee 0.0111%
Short position overnight fee -0.0330%
Overnight fee time 22:00 (UTC)
Spread 0.030

BTC/USD

57,015.05 Price
+4.260% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading